Europe

EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules
EMA Recommends Remdesivir for Treatment of COVID-19 Under Compassionate-Use Rules
Motley Fool
Gilead Sciences
Europe
COVID-19
remdesivir
Flag link:
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
Motley Fool
chloroquine
hydroxychloroquine
FDA
Europe
COVID-19
Flag link:
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Fierce Pharma
Mylan
Pfizer
Upjohn
Europe
M&A
Flag link:
Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients
Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients
Fierce Pharma
Novartis
Europe
Donald Trump
gene therapy
Kymriah
COVID-19
Flag link:
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
Xconomy
LSP
life sciences
Bristol-Myers Squibb
Otsuka
Europe
Flag link:
Few groups have developed Covid-19 diagnostics – but this will change
Few groups have developed Covid-19 diagnostics – but this will change
EP Vantage
diagnostics
United States
Europe
FDA
COVID-19
coronavirus
Flag link:
European regulators expand use of AbbVie's two-month hep C regimen
European regulators expand use of AbbVie's two-month hep C regimen
Endpoints
AbbVie
Europe
hepatitis C
Maviret
Flag link:
Boehringer bags CHMP backing for Ofev in rare lung disease
Boehringer bags CHMP backing for Ofev in rare lung disease
Pharmaforum
Boehringer Ingelheim
Ofev
Europe
CHMP
scleroderma
Flag link:
Pharma industry body urges “ambition” in UK-EU trade talks
Pharma industry body urges “ambition” in UK-EU trade talks
Pharmaforum
trade
UK
Europe
ABPI
Flag link:
GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults
GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults
Pharmaceutical Business Review
GSK
Innoviva
EMA
Europe
asthma
Trelegy Elipta
Flag link:
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel
Pfizer Gains European Approval for Amyloidosis Drug Vyndaqel
Fierce Biotech
Europe
Pfizer
transthyretin amyloidosis
ATTR-CM
Vyndaqel
Flag link:
Dutch biotech sector feel benefits of EMA move, says industry leader
Dutch biotech sector feel benefits of EMA move, says industry leader
Pharmaforum
EMA
Europe
The Netherlands
Brexit
biotech
Flag link:
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Motley Fool
Bristol-Myers Squibb
Europe
Opdivo
Yervoy
non-small cell lung cancer
Flag link:
JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
Fierce Pharma
Amarin
Vascepa
Epanova
AstraZeneca
Acasti
Europe
Flag link:
ViiV files first-in-class HIV drug in Europe
ViiV files first-in-class HIV drug in Europe
Pharmaforum
ViiV Healthcare
Europe
HIV
fostemsavir
Flag link:
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
AbbVie
Allergan
antitrust
M&A
brazikumab
Europe
Flag link:
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche
Flag link:
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
Pharmaceutical Business Review
AstraZeneca
Seroquel
Seroquel XR
Russia
Europe
Cheplapharm
Flag link:
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
osteoporosis
Amgen
Europe
romosozumab
Evenity
Flag link:
US biosimilar launches about to turn a corner
US biosimilar launches about to turn a corner
Endpoints
biosimilars
Europe
Flag link:

Pages